← Association for Accessible Medicines
FDANonrulemakingFDA-2018-D-4629

Survey Methodologies to Assess REMS Goals That Relate to Knowledge; Draft Guidance for Industry; Availability

RIN
—
Last modified
Apr 3, 2019
Comment window
closed 2674d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Apr 3, 2019 and Apr 3, 2019. 0 other organizations filed here. The comment window closed 2674d ago.

What Association for Accessible Medicines filed (1)

Apr 3, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2018-D-4629-0005

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2018-D-4628: REMS Assessment: Planning and Reporting; Draft Guidance for Industry and FDA-2018-D-4629: Survey Methodologies to Assess REMS Goals That Relate to Knowledge; Draft Guidance for Industry.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →